• Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

  • Apr 30 2024
  • Length: 34 mins
  • Podcast

Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents By cover art

Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

Listen for free

View show details

  • Summary

  • Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Biological Sciences
Show more Show less

What listeners say about Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available